Voyager Therapeutics
VYGR
VYGR
78 hedge funds and large institutions have $96.8M invested in Voyager Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less capital invested
Capital invested by funds: $130M → $96.8M (-$33M)
29% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 28
59% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 39
Holders
78
Holding in Top 10
1
Calls
$718K
Puts
$747K
Top Buyers
| 1 | +$5.63M | |
| 2 | +$2.14M | |
| 3 | +$1.67M | |
| 4 |
Morgan Stanley
New York
|
+$1.12M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$744K |
Top Sellers
| 1 | -$6.52M | |
| 2 | -$6.52M | |
| 3 | -$4.16M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.77M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.67M |